Keros CEO Jasbir Seehra to present at Guggenheim SMID Cap Biotech Conference on Feb 6

Keros Therapeutics, Inc.

Chair and CEO Jasbir Seehra will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference.
Presentation scheduled for Thursday, February 6, 2025, at 10:00 a.m. Eastern time.
Live webcast and 90-day replay available via Keros investor relations page.

item 7.01 item 9.01

Keros Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001664710-25-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.